Bill > HB2874

This bill amends the Illinois Controlled Substances Act to clarify that the existing restrictions on over-the-counter sales of ephedrine do not apply to ephedrine-containing products when they are dispensed or delivered by a licensed practitioner or pharmacy through a valid prescription. Specifically, the bill adds a new subsection (f) to Section 216 of the Act, which exempts prescription ephedrine products from the current limitations on sale and marketing. The existing law already had complex provisions regulating ephedrine products, including restrictions on packaging, labeling, and marketing for certain indications like weight loss or stimulation. The new provision ensures that when a properly authorized healthcare provider prescribes an ephedrine-containing medication for a legitimate medical purpose, that prescription can be filled without being subject to the previous over-the-counter sales limitations. This change appears designed to maintain patient access to medically necessary ephedrine-based treatments while preserving the original law's intent to prevent potential misuse of these substances.

Health and Social Services

https://www.ilga.gov/legislation/BillStatus.asp?DocNum=2874&GAID=18&DocTypeID=HB&SessionID=114&GA=104